The stem cell banking is the practice of preserving blood cell from a new born baby for future use. The preserved blood is used in medical therapies for a variety of diseases, which include conditions such as sarcoma, leukemia, immune conditions, lymphoma, and metabolic disorders. Continue reading →

According to research published in Nature Communications, investigators developed a new single-cell multi-omic approach to identify leukemic stem cells and characterized cancer stem cells in the context of acute myeloid leukemia (AML), which the investigators think may be able to translate to other tumor types.1 MutaSeq, the new method created by investigators from the Centre for Genomic Regulation (CRG) and the European Molecular Biology Laboratory (EMBL), works to distinguish between pre-leukemic stem cells, leukemic stem cells, and healthy hematopoietic stem cells.2 There are a huge number of small molecule drugs out there with demonstrated clinical safety, but deciding which cancers and more specifically which patients these drugs are well suited for is a daunting task, Lars Steinmetz, professor at Stanford University and author of the paper, said in a press release. Our method can identify drug targets that might not have been tested in the right context. These tests will need to be carried out in controlled clinical studies, but knowing what to try is an important first step. Continue reading →

The UCLA study has found that a one-time injection of an experimental stem cell therapy can promote recovery by repairing brain damage and improving memory function in mice with conditions that replicate human strokes and dementia. Dementia is characterised by an array of symptoms including problems with memory, attention, communication, and physical coordination with the two most common causes of dementia bring Alzheimers disease and white matter strokes. The study has been published inScience Translational Medicine. Continue reading →

26 April 2021 Adult human skin cells have been reprogrammed to form three-dimensional structures similar to early human embryos by a team led by Professor Jose Polo at Monash University, Australia (see BioNews 1088). Called 'iBlastoids', they could potentially enable us to learn how early human embryos develop and implant in the uterus. The studies could also lead to medical treatments for conditions such as infertility, miscarriage, developmental disorders and genetic diseases Continue reading →

In 2009, Time magazine declared cultured meat one of their top 50 inventions of the year for its potential to curb the carbon footprint of industrial farming. This promising idea has since become a booming industry. Ever since Dutch researcher Mark Post debuted the first lab-grown hamburger in 2013 a $325,000 patty with an intense flavor that took two years to dish up nearly 60 companies have sprung up around the globe in pursuit of growing the perfect cut of cultured meat. Continue reading →

By: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research The U.S. Food and Drug Administration plays a vital role in facilitating the development and availability of innovative medical products. Continue reading →

URBANA, Ill., April 26, 2021 /PRNewswire/ -- A team from the University of Illinois Urbana-Champaign's Grainger College of Engineering and Mayo Clinic have developed a new technique for creating "microcancer" cell cultures. Continue reading →

If you feel your brain power diminishing as you advance into middle age and beyond, blame your neural stem cells. Ina new study published inCell Stem Cell, a team led by USC Stem Cell scientistMichael Bonaguididemonstrates that neural stem cellsthe stem cells of the nervous systemage rapidly. There is chronological aging, and there is biological aging, and they are not the same thing, said Bonaguidi, an Assistant Professor of Stem Cell Biology and Regenerative Medicine, Gerontology and Biomedical Engineering at theKeck School of Medicine of USC. Continue reading →